| |
| |
|
| Insider
Information: |
Herring Joseph L |
| Relationship: |
|
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
38,290 |
|
|
Indirect Shares
|
6,042 |
|
|
| Direct
Value |
$4,015,196 |
|
|
|
Indirect Value
|
$1,061,705 |
|
|
| Total
Shares |
44,332 |
|
|
| Total
Value |
$5,076,902 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Covance Inc |
CVD |
Chairman and CEO, Dire... |
2015-02-19 |
0 |
2015-02-19 |
0 |
Premium* |
|
|
Team Health Holdings Inc. |
TMH |
Director |
2016-05-21 |
2,982 |
2013-11-18 |
0 |
Premium* |
|
|
Laboratory Corp of America |
LH |
CEO of Covance Drug Di... |
2015-07-31 |
10,404 |
2015-02-19 |
4,508 |
Premium* |
|
|
Henry Schein Inc |
HSIC |
|
2024-03-04 |
24,904 |
2018-03-02 |
1,534 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
102 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CVD |
Covance Inc |
Chairman and CEO |
• • – |
2008-12-19 |
4 |
D |
$41.00 |
$837,015 |
D/D |
(20,415) |
163,590 |
0 |
- |
|
| CVD |
Covance Inc |
Chairman and CEO |
• • – |
2013-06-27 |
4 |
S |
$77.00 |
$908,292 |
D/D |
(11,796) |
329,704 |
0 |
- |
|
| CVD |
Covance Inc |
Chairman and CEO |
• • – |
2012-11-06 |
4 |
OE |
$22.95 |
$936,360 |
D/D |
40,800 |
315,063 |
0 |
- |
|
| CVD |
Covance Inc |
Chairman and CEO |
• • – |
2006-12-20 |
4 |
D |
$59.33 |
$970,283 |
D/D |
(16,354) |
130,764 |
0 |
- |
|
| CVD |
Covance Inc |
President and COO |
• – – |
2004-02-17 |
4 |
S |
$30.76 |
$1,184,252 |
D/D |
(38,500) |
87,152 |
|
- |
|
| LH |
Laboratory Corp of Americ... |
CEO of Covance Drug Division |
• • – |
2015-07-31 |
4 |
D |
$127.29 |
$1,220,202 |
D/D |
(9,586) |
10,404 |
0 |
- |
|
| CVD |
Covance Inc |
Chairman and CEO |
• • – |
2014-09-09 |
4 |
OE |
$42.32 |
$1,362,704 |
D/D |
32,200 |
277,098 |
0 |
- |
|
| CVD |
Covance Inc |
Chairman and CEO |
• • – |
2007-05-17 |
4 |
S |
$65.07 |
$1,463,985 |
D/D |
(22,500) |
215,988 |
0 |
- |
|
| CVD |
Covance Inc |
Chairman and CEO |
• • – |
2011-05-20 |
4 |
S |
$59.41 |
$1,500,043 |
D/D |
(25,249) |
257,385 |
0 |
- |
|
| CVD |
Covance Inc |
Chairman and CEO |
• • – |
2013-12-17 |
4 |
D |
$84.31 |
$1,615,801 |
D/D |
(19,165) |
210,539 |
0 |
- |
|
| CVD |
Covance Inc |
Chairman and CEO |
• • – |
2007-12-20 |
4 |
D |
$87.11 |
$1,703,077 |
D/D |
(19,552) |
196,436 |
0 |
- |
|
| CVD |
Covance Inc |
Chairman and CEO |
• • – |
2008-09-10 |
4 |
S |
$97.01 |
$1,717,010 |
D/D |
(17,700) |
184,005 |
0 |
- |
|
| CVD |
Covance Inc |
Chairman and CEO |
• • – |
2013-06-19 |
4 |
S |
$78.03 |
$1,747,170 |
D/D |
(22,391) |
336,704 |
0 |
- |
|
| CVD |
Covance Inc |
Chairman and CEO |
• • – |
2012-11-06 |
4 |
AS |
$53.00 |
$2,162,400 |
D/D |
(40,800) |
274,263 |
0 |
- |
|
| CVD |
Covance Inc |
Chairman and CEO |
• • – |
2007-05-16 |
4 |
S |
$65.46 |
$2,454,900 |
D/D |
(37,500) |
215,988 |
0 |
- |
|
| CVD |
Covance Inc |
Chairman and CEO |
• • – |
2014-09-09 |
4 |
AS |
$85.13 |
$2,741,025 |
D/D |
(32,200) |
244,898 |
0 |
- |
|
| CVD |
Covance Inc |
Chairman and CEO |
• • – |
2008-09-11 |
4 |
S |
$96.37 |
$3,112,670 |
D/D |
(32,300) |
184,005 |
0 |
- |
|
| CVD |
Covance Inc |
Chairman and CEO |
• • – |
2007-12-31 |
4 |
S |
$87.09 |
$3,135,373 |
D/D |
(36,000) |
156,436 |
0 |
- |
|
| CVD |
Covance Inc |
Chairman and CEO |
• • – |
2014-12-18 |
4 |
AS |
$103.02 |
$3,367,806 |
D/D |
(32,692) |
170,568 |
0 |
- |
|
| CVD |
Covance Inc |
Chairman and CEO |
• • – |
2013-11-04 |
4 |
OE |
$39.80 |
$3,745,180 |
D/D |
94,100 |
323,804 |
0 |
- |
|
| CVD |
Covance Inc |
Chairman and CEO |
• • – |
2014-12-17 |
4 |
D |
$102.61 |
$4,272,475 |
D/D |
(41,638) |
203,260 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
CEO of Covance Drug Division |
• • – |
2015-02-25 |
4 |
S |
$121.56 |
$4,485,430 |
D/D |
(36,876) |
0 |
0 |
- |
|
| CVD |
Covance Inc |
Chairman and CEO |
• • – |
2014-02-07 |
4 |
OE |
$56.93 |
$5,271,718 |
D/D |
92,600 |
303,139 |
0 |
- |
|
| CVD |
Covance Inc |
Chairman and CEO |
• • – |
2015-02-19 |
4 |
D |
$107.19 |
$5,917,107 |
D/D |
(55,204) |
137,229 |
0 |
- |
|
| CVD |
Covance Inc |
Chairman and CEO |
• • – |
2013-11-04 |
4 |
AS |
$87.32 |
$8,216,812 |
D/D |
(94,100) |
229,704 |
0 |
- |
|
102 Records found
|
|
Page 4 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
